News
Latest News
read obout major events in our firm:
major projects, partner news and other events of importance.
You can also leave us a message
ECM Partners Inc. appoints Peter Prock as Chairman of FAMAR Group Board of Directors
ECM Partners Inc. appoints Peter Prock as Chairman of FAMAR Group Board of Directors ECM Partners Inc., FAMAR’s major shareholder, announced today that Peter Prock is appointed as the new Chairman of the Board of Directors of FAMAR Group, a leading...
SIX RAYS HOLDING appointed Claudio Albrecht to serve as non executive director of SIX RAYS HOLDING.
SIX RAYS HOLDING appointed Claudio Albrecht to serve as non executive directors of SIX RAYS HOLDING. SIX RAYS HOLDING based out of SINGAPORE – as a holding company being active in: STERILE INJECTABLES: Build on strong track record, with focus on products...
Polpharma Group BV appointed Peter Prock to serve as non executive director of Polpharma Group BV.
Polpharma Group BV appointed Peter Prock to serve as non executive directors of Polpharma Group BV. Polpharma Group is one of the leading healthcare companies in CEE, CIS and Central Asia, focused on delivering high-quality and affordable...
MS Pharma appointed both Claudio Albrecht and Peter Prock to serve as non executive directors of MS Pharma.
MS Pharma appointed both Claudio Albrecht and Peter Prock to serve as non executive directors of MS Pharma. MS Pharma, a leading pharmaceutical company in the META region with plans to grow into other international markets, having one of the largest...
APP was acting as a strategic transaction advisor to the sellers of Genepharm in their endeavor to sell their business
MS Pharma, a fast growing pharmaceutical company based in Jordan and operating across the Middle East, Turkey and Africa, announced today that it has entered into an agreement to acquire 100% of the outstanding shares in Genepharm, a leading European pharmaceutical...
Peter Prock becomes non executive director of Nupharm
As already reported, APP advised funds controlled by APAX an the acquisition of Inventfarma and Neuraxpharm - the 2 first companies forming Nupharm. Following the creation of Nupharm, Claudio Albrecht assumed the role of a non executive Director from...
contact us
Albrecht, Prock & Partners AG
Bödlistrasse 3c
CH-6314 Unteraegeri - Zug, Switzerland
office(at)ca-pp.net